Literature DB >> 23549399

Human papillomavirus infection and the multistage carcinogenesis of cervical cancer.

Mark Schiffman1, Nicolas Wentzensen.   

Abstract

This short review outlines our understanding of cervical cancer precursors, concentrating on the central etiologic role of persistent human papillomavirus infection. The stages of cervical carcinogenesis are better understood than for most other major cancers, providing a successful cancer etiology and prevention model.

Entities:  

Mesh：

Year:  2013        PMID： 23549399      PMCID： PMC3711590          DOI： 10.1158/1055-9965.EPI-12-1406

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN： 1055-9965            Impact factor:   4.254


  50 in total

Review 1.  Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts.

Authors:  Vikrant V Sahasrabuddhe; Patricia Luhn; Nicolas Wentzensen
Journal:  Future Microbiol       Date:  2011-09       Impact factor: 3.165

2.  American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.

Authors:  Debbie Saslow; Diane Solomon; Herschel W Lawson; Maureen Killackey; Shalini L Kulasingam; Joanna Cain; Francisco A R Garcia; Ann T Moriarty; Alan G Waxman; David C Wilbur; Nicolas Wentzensen; Levi S Downs; Mark Spitzer; Anna-Barbara Moscicki; Eduardo L Franco; Mark H Stoler; Mark Schiffman; Philip E Castle; Evan R Myers
Journal:  CA Cancer J Clin       Date:  2012-03-14       Impact factor: 508.702

3.  Methylation of human papillomavirus type 16 genome and risk of cervical precancer in a Costa Rican population.

Authors:  Lisa Mirabello; Chang Sun; Arpita Ghosh; Ana C Rodriguez; Mark Schiffman; Nicolas Wentzensen; Allan Hildesheim; Rolando Herrero; Sholom Wacholder; Attila Lorincz; Robert D Burk
Journal:  J Natl Cancer Inst       Date:  2012-03-23       Impact factor: 13.506

Review 4.  The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology.

Authors:  Teresa M Darragh; Terence J Colgan; J Thomas Cox; Debra S Heller; Michael R Henry; Ronald D Luff; Timothy McCalmont; Ritu Nayar; Joel M Palefsky; Mark H Stoler; Edward J Wilkinson; Richard J Zaino; David C Wilbur
Journal:  J Low Genit Tract Dis       Date:  2012-07       Impact factor: 1.925

5.  Switch from cytology-based to human papillomavirus test-based cervical screening: implications for colposcopy.

Authors:  Carolina Porras; Nicolas Wentzensen; Ana C Rodríguez; Jorge Morales; Robert D Burk; Mario Alfaro; Martha Hutchinson; Rolando Herrero; Allan Hildesheim; Mark E Sherman; Sholom Wacholder; Diane Solomon; Mark Schiffman
Journal:  Int J Cancer       Date:  2011-08-02       Impact factor: 7.396

6.  Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice.

Authors:  Hormuzd A Katki; Walter K Kinney; Barbara Fetterman; Thomas Lorey; Nancy E Poitras; Li Cheung; Franklin Demuth; Mark Schiffman; Sholom Wacholder; Philip E Castle
Journal:  Lancet Oncol       Date:  2011-06-16       Impact factor: 41.316

7.  A discrete population of squamocolumnar junction cells implicated in the pathogenesis of cervical cancer.

Authors:  Michael Herfs; Yusuke Yamamoto; Anna Laury; Xia Wang; Marisa R Nucci; Margaret E McLaughlin-Drubin; Karl Münger; Sarah Feldman; Frank D McKeon; Wa Xian; Christopher P Crum
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-11       Impact factor: 11.205

8.  Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence.

Authors:  Susanne K Kjær; Kirsten Frederiksen; Christian Munk; Thomas Iftner
Journal:  J Natl Cancer Inst       Date:  2010-09-14       Impact factor: 13.506

9.  Prevalence of genotype-specific human papillomavirus infection and cervical neoplasia in Taiwan: a community-based survey of 10,602 women.

Authors:  Hui-Chi Chen; San-Lin You; Chang-Yao Hsieh; Mark Schiffman; Ching-Yu Lin; Mei-Hung Pan; Yi-Chun Chou; Kai-Li Liaw; Ann W Hsing; Chien-Jen Chen
Journal:  Int J Cancer       Date:  2010-11-16       Impact factor: 7.396

Review 10.  Understanding and learning from the success of prophylactic human papillomavirus vaccines.

Authors:  John T Schiller; Douglas R Lowy
Journal:  Nat Rev Microbiol       Date:  2012-09-10       Impact factor: 60.633
View more
  96 in total

1.  HPV vaccination to prevent cervical cancer and other HPV-associated disease: from basic science to effective interventions.

Authors:  Douglas R Lowy
Journal:  J Clin Invest       Date:  2016-01-04       Impact factor: 14.808

Review 2.  Human papillomavirus genome variants.

Authors:  Robert D Burk; Ariana Harari; Zigui Chen
Journal:  Virology       Date:  2013-08-31       Impact factor: 3.616

3.  [Epidemiology, prevention and early detection of cervical cancer].

Authors:  Nicolas Wentzensen
Journal:  Onkologe (Berl)       Date:  2016-08-04       Impact factor: 0.234

4.  Strategies for screening and early detection of anal cancers: A narrative and systematic review and meta-analysis of cytology, HPV testing, and other biomarkers.

Authors:  Megan A Clarke; Nicolas Wentzensen
Journal:  Cancer Cytopathol       Date:  2018-05-24       Impact factor: 5.284

5.  IL-17 suppresses immune effector functions in human papillomavirus-associated epithelial hyperplasia.

Authors:  Christina Gosmann; Stephen R Mattarollo; Jennifer A Bridge; Ian H Frazer; Antje Blumenthal
Journal:  J Immunol       Date:  2014-07-25       Impact factor: 5.422

6.  HPV16 CpG methyl-haplotypes are associated with cervix precancer and cancer in the Guanacaste natural history study.

Authors:  Marina Frimer; Chang Sun; Thomas McAndrew; Benjamin Smith; Ariana Harari; Zigui Chen; Lisa Mirabello; Nicolas Wentzensen; Gary L Goldberg; Ana C Rodriguez; Mark Schiffman; Robert D Burk
Journal:  Gynecol Oncol       Date:  2015-05-19       Impact factor: 5.482

7.  Human papillomavirus genomics: past, present and future.

Authors:  Ariana Harari; Zigui Chen; Robert D Burk
Journal:  Curr Probl Dermatol       Date:  2014-03-13

8.  Human Papillomavirus DNA Methylation as a Biomarker for Cervical Precancer: Consistency across 12 Genotypes and Potential Impact on Management of HPV-Positive Women.

Authors:  Megan A Clarke; Ana Gradissimo; Nicolas Wentzensen; Robert D Burk; Mark Schiffman; Jessica Lam; Christopher C Sollecito; Barbara Fetterman; Thomas Lorey; Nancy Poitras; Tina R Raine-Bennett; Philip E Castle
Journal:  Clin Cancer Res       Date:  2018-02-02       Impact factor: 12.531

9.  Persistent infection with human papillomavirus 16 or 18 is strongly linked with high-grade cervical disease.

Authors:  David Radley; Alfred Saah; Margaret Stanley
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

10.  Are uninsured women in a national screening program having longer intervals between cervical cancer screening tests?

Authors:  Shelton J Bartley; Vicki Benard; Eric Tai; Tanner Rockwell; Kristy Kenney; Lisa C Richardson
Journal:  Prev Med       Date:  2020-04-01       Impact factor: 4.018
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.